Enrich Therapeutics
Enrich Therapeutics: The next-generation, image-based single-cell sorter. Enrich Therapeutics Team: Xueqi Liu Qi Zhao
Read MoreMIDA Project
MIDA Project is developing a high throughput screen test for detection of MVID among patients with diarrhea. MIDA Project Team: Ludmilla Kvochina
Read MoreELIV5
ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence. ELIV5 Team: Choukri Ben Mamoun
Read MoreQlear Chemicals
Qlear Chemicals We develop novel permeabilization and optical clearing reagents for 3D imaging of intact, grossed anatomic pathology samples. Qlear Chemicals Team: Elif Alpoge
Read MoreSmell-RS
Smell-RS is developing a digital diagnostic device for testing olfactory function, which is an early symptom of neurodegenerative diseases that affect 10% of the population. Smell-RS Team: Andreas Keller, CEO
Read MoreUnicrobe
We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development
Read MoreiLight Biotechnologies
Genetic tools for non-invasive activation and detection of biological processes with deeply penetrating near-infrared light that will make drug discovery process more efficient. iLight Biotechnologies Team: Daria Shcherbakova, PhD. – Co-founder, CEO Vladislav Verkhusha, PhD. – Co-founder, CSO
Read MoreMirna Analytics
Mirna Analytics is developing a non-invasive platform tool for prognostic and diagnostic monitoring. Our current focus is on pulmonary hypertension. Team: Gabriele Grunig, DVM, PhD – Co-founder, President Serhiy Pylawka, RN, MS – Co-founder, Science Officer
Read MoreMouSensor, Inc.
MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder
Read MoreNew York R&D Center for Translational Medicine and Therapeutics, Inc. (Ny.TmT)
The product we’re developing is provides an intervention for tendon and ligament injury repair and regeneration and tendinopathy treatment. New York R&D Center for Translational Medicine and Therapeutics, Inc. (Ny.TmT) Team: Herb Sun Angela Wang Daniel Leong
Read More